A cost-effectiveness comparison of liquor carbonis distillate solution and calcipotriol cream in the treatment of moderate chronic plaque psoriasis.
Alora-Palli
Maria B
MB
Brouda
Irina
I
Green
Barbara
B
Kimball
Alexandra B
AB
D000279:Administration, Cutaneous; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D003033:Coal Tar / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics; D008404:Massachusetts; D004366:Nonprescription Drugs / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy* / Q000191:economics / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016037:Single-Blind Method; D016896:Treatment Outcome
D003879:Dermatologic Agents; D004366:Nonprescription Drugs; C055085:calcipotriene; D003033:Coal Tar; D002117:Calcitriol